ACT Genomics and Nan Shan Life Insurance Cooperates To Promote High-Quality Cancer Precision Medicine Services

2020-09-29

The quality of cancer treatment for patients receives more and more attentions. Nowadays, the development of cancer drugs is fast-progressing and oncologists can use cancer genomic profiling to treat cancer patients for precision medicine.  Appropriate treatment strategy according to genomic mutations can avoid waste of medical resources. Cancer genomic profiling service can enhance quality of cancer treatment, provide more treatmet opportunities and save medical expenditures. To provide better care for cancer patients in the wave of cancer precision medicine, strategic cooperations among biotech and insurance company are on the rise. 

We are happy to announce that ACT Genomics cooperates with Nan Shan Life Insurance to launch a precision medicine project which actively promotes our high-quality cancer genomic profiling services to more cancer patients.  :

Project Time  : From today to 2021.09.25 
Project Content :  Nan Shan Life Insurance clients can have 10 % off discount on all ACT Genomics' cancer genomic profiling services

➡️ News for precision medicine project :  https://bit.ly/3kXcMgu
➡️ ACT Genomics services : https://bit.ly/2GfJ6fN